SharkNinja (SN) Stock

In the most recent trading session, SharkNinja, Inc. (SN) finished at $97.25, which is a decrease of 1.31% compared to the day before.

JP Morgan has reinforced its "overweight" rating for Smith & Nephew PLC (LSE:SN), believing the medical device company is undervalued and trading at low levels, which could lead to a significant increase in value. Even though the wider European medtech industry faces difficulties, S&N is seen as a strong value choice with good chances for recovery.

Investors frequently depend on analyst recommendations when choosing to buy, sell, or hold a stock. Changes in ratings from these analysts, who work for brokerage firms, can impact a stock's price, but how significant are they really?

SharkNinja, Inc. (SN) reported quarterly earnings of $1.21 per share, which is higher than the Zacks Consensus Estimate of $1.14 per share. This is an increase compared to earnings of $0.95 per share from the same period last year.

Smith & Nephew PLC, a British medical equipment maker, has reduced its revenue forecast for the year due to lower demand and pricing challenges in China. The company, which is listed on the FTSE 100, now anticipates a revenue growth of 4.5%, down from the earlier expectation of 5-6%.

SharkNinja, Inc. (SN) will announce its third-quarter 2024 results on October 31, before the market opens. You can keep track of all quarterly announcements by checking the Zacks Earnings Calendar.

At the end of the last trading day, SharkNinja, Inc. (SN) was priced at $109.32, which represents a 1.42% increase compared to the previous day.

SharkNinja, Inc. (SN) has the right mix of two important factors that could lead to better earnings in its next report. Be ready for the main expectations.

If a stock continues to perform well, it can be beneficial to hold onto it for a longer period.